- Home
- ONEG vs BFRI Comparison
ONEG vs BFRI Comparison
Compare ONEG & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | BFRI |
|---|---|---|
| Founded | 2021 | 1997 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5M | 16.3M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ONEG | BFRI |
|---|---|---|
| Price | $1.04 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 27.0K | ★ 625.4K |
| Earning Date | 01-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 67.70 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $0.72 | $0.57 |
| 52 Week High | $14.95 | $1.66 |
Technical Indicators
Market Signals| Indicator | ONEG | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 55.97 |
| Support Level | $1.00 | $0.78 |
| Resistance Level | $1.06 | N/A |
| Average True Range (ATR) | 0.02 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 65.87 | 42.81 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction projects include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.